First Horizon Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
First Horizon Advisors's HALO Position: Q2 2025 in Review
First Horizon Advisors reduced its Halozyme (HALO) stake by 38% in Q2 2025, selling an estimated $23.5K and leaving 677 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.
First Horizon Advisors first reported a position in HALO in Q2 2020 and has held it in 21 quarters since. The position peaked at $73.8K in Q3 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.
- First Horizon Advisors held 677 shares of Halozyme worth $35.2K as of Q2 2025.
- First Horizon Advisors sold 413 Halozyme shares in Q2 2025, an estimated $23.5K.
- Halozyme made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1188 holding.
- First Horizon Advisors first reported a position in Halozyme in Q2 2020 and has held it in 21 quarters since.
- First Horizon Advisors's Halozyme position peaked at $73.8K in Q3 2024.
- 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.